Search

Tandem Diabetes Care Inc

Затворен

СекторЗдравеопазване

17.17 0.23

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

16.95

Максимум

17.25

Ключови измерители

By Trading Economics

Приходи

-20M

-20M

Продажби

-43M

247M

EPS

-0.3

Марж на печалбата

-8.249

Служители

2,500

EBITDA

-25M

-14M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+68.75% upside

Дивиденти

By Acuity

Следващи печалби

6.08.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-121M

1.2B

Предишно отваряне

16.94

Предишно затваряне

17.17

Настроения в новините

By Acuity

50%

50%

146 / 340 Класиране в Healthcare

Tandem Diabetes Care Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

24.07.2026 г., 14:02 ч. UTC

Tandem Diabetes Care Inc shares are lower today, with no specific news identified. Broader market concerns follow a significant sell-off on Thursday.

21.07.2026 г., 19:06 ч. UTC

Tandem Diabetes Care is lower today, driven by declines in the Health Care Equipment sub-sector. The asset has fallen steadily after an early high.

20.07.2026 г., 17:26 ч. UTC

Tandem Diabetes Care Inc shares are higher today, recovering from an early dip. The stock has gained significantly since last month’s close.

Сравнение с други в отрасъла

Ценова промяна

Tandem Diabetes Care Inc Прогноза

Ценова цел

By TipRanks

68.75% нагоре

12-месечна прогноза

Среден 28.89 USD  68.75%

Висок 55 USD

Нисък 15.5 USD

Според 15 анализатори от Wall Street, предложили 12-месечна ценова цел за Tandem Diabetes Care Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

15 ratings

9

Купи

6

Задържане

0

Продай

Настроение

By Acuity

146 / 340 Класиране в Здравеопазване

Настроения в новините

Neutral

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Tandem Diabetes Care Inc

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
help-icon Live chat